TBPH Cost of Revenue
Theravance Biopharma Inc · Cost of Revenue
TBPH Cost of Revenue
Latest reported$11.06Mperiod ending
TBPH Cost of Revenue ($3.84M → $11.06M)
Annual cost of revenue
High-resolution chart · PNG
TBPH cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 5,515,000 | |
| 37,643,000 | |
| 40,621,000 | |
| 63,392,000 | |
| 193,657,000 | |
| 0 | |
| 0 | |
| 715,000 | |
| 6,030,000 | |
| 2,894,000 | |
| 4,657,000 | |
| 4,058,000 | |
| 120,579,000 | |
| 113,995,000 | |
| 3,844,000 |